MP Materials Corp (MP)vsNovartis AG ADR (NVS)

MP

MP Materials Corp

NYSE

$53.74

+0.84%

BASIC MATERIALS · Cap: $9.47B

NVS

Novartis AG ADR

NYSE

$150.75

+1.44%

HEALTHCARE · Cap: $286.27B

⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Novartis AG ADR generates 20475% more annual revenue ($56.67B vs $275.46M). NVS leads profitability with a 24.7% profit margin vs -31.2%. NVS earns a higher WallStSmart Score of 51/100 (C-).

MP

Avoid

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 5.0Quality: 7.5

Piotroski: 4/9Altman Z: 1.13

NVS

Buy

out of 100

Grade: C-

Growth: 4.0Profit: 9.0Value: 4.7Quality: 6.5

Piotroski: 4/9Altman Z: 1.96

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MP.

NVSSignificantly Overvalued (-243.7%)

Margin of Safety

-243.7%

Fair Value

$48.62

Current Price

$150.75

$102.13 premium

UndervaluedFair: $48.62Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MP1 strengths · Avg: 10.0/10

Revenue GrowthGrowth

70.0%10/10

Revenue surging 70.0% year-over-year

NVS5 strengths · Avg: 9.0/10

Market CapQuality

$286.27B10/10

Mega-cap, among the largest globally

Return on EquityProfitability

30.8%10/10

Every $100 of equity generates 31 in profit

Profit MarginProfitability

24.7%9/10

Keeps 25 of every $100 in revenue as profit

Operating MarginProfitability

27.8%8/10

Strong operational efficiency at 27.8%

Free Cash FlowQuality

$1.64B8/10

Generating 1.6B in free cash flow

Areas to Watch

MP4 concerns · Avg: 2.0/10

Return on EquityProfitability

-5.0%2/10

ROE of -5.0% — below average capital efficiency

EPS GrowthGrowth

-55.6%2/10

Earnings declined 55.6%

Free Cash FlowQuality

$-109.26M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth

1.132/10

Distress zone — elevated risk

NVS4 concerns · Avg: 3.0/10

Revenue GrowthGrowth

2.2%4/10

2.2% revenue growth

Altman Z-ScoreHealth

1.964/10

Grey zone — moderate risk

PEG RatioValuation

2.542/10

Expensive relative to growth rate

EPS GrowthGrowth

-11.6%2/10

Earnings declined 11.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : MP

The strongest argument for MP centers on Revenue Growth. Revenue growth of 70.0% demonstrates continued momentum.

Bull Case : NVS

The strongest argument for NVS centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 24.7% and operating margin at 27.8%.

Bear Case : MP

The primary concerns for MP are Return on Equity, EPS Growth, Free Cash Flow.

Bear Case : NVS

The primary concerns for NVS are Revenue Growth, Altman Z-Score, PEG Ratio.

Key Dynamics to Monitor

MP profiles as a hypergrowth stock while NVS is a value play — different risk/reward profiles.

MP carries more volatility with a beta of 1.62 — expect wider price swings.

MP is growing revenue faster at 70.0% — sustainability is the question.

NVS generates stronger free cash flow (1.6B), providing more financial flexibility.

Bottom Line

NVS scores higher overall (51/100 vs 29/100), backed by strong 24.7% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

MP Materials Corp

BASIC MATERIALS · OTHER INDUSTRIAL METALS & MINING · USA

MP Materials Corp. The company is headquartered in Las Vegas, Nevada.

Novartis AG ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

Visit Website →

Compare with Other OTHER INDUSTRIAL METALS & MINING Stocks

MP vs BHP MP vs RIO MP vs VALE MP vs TECK MP vs USAR NVS vs BHP NVS vs RIO NVS vs VALE NVS vs TECK NVS vs USAR

Want to dig deeper into these stocks?

Full MP Analysis →Full NVS Analysis →